EFLUELDA susp inj 2024/2025 ser pré 0.7 ml
7680677040221
CH-67704
J07BB02
08.08.
Reimbursement limitations:
0808 NEU
La prise en charge des coûts des vaccins au titre de mesure préventive dans le …
1 / 3
google
Details
- Product number
- 6770404
- CPT
- -
- Packaging group
- 1
- Unit
- Fertigspritze(n)
- Composition
- haemagglutininum influenzae A (H1N1) (Virus souche A/Victoria/4897/2022 (H1N1)-like: reassortant virus IVR-238 derived from A/Victoria/4897/2022) 60 µg, haemagglutininum influenzae A (H3N2) (Virus souche A/Thailand/8/2022 (H3N2)-like: reassortant virus SAN-022 derived from A/California/122/2022) 60 µg, haemagglutininum influenzae B (Virus souche B/Austria/1359417/2021-like: derived from B/Michigan/01/2021 (Victoria lineage)(wild type)) 60 µg, haemagglutininum influenzae B (Virus souche B/Phuket/3073/2013 (Yamagata lineage) (wild type)) 60 µg, natrii chloridum, dinatrii phosphas, natrii dihydrogenophosphas anhydricus, octoxinolum-9, aqua ad iniectabile q.s. ad suspensionem pro 0.7 ml corresp. natrium 2.72 mg.
Articles (1)
Efluelda 0.7 ml, suspension injectable en seringue préremplie
suspension
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
60.0 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
60.0 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
60.0 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
60.0 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
2.72 MG | Substance | HBESI |
Authorization holder
Sanofi-Aventis (Suisse) SA
1214 Vernier
Authorization information
- Swissmedic authorization number
- 67704
- Drug name
- Efluelda, suspension injectable en seringue préremplie
- Galenic form
- INJFS
- ATC Code
- J07BB02
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 21/07/2021
- Authorization expiration date
- 20/07/2026
- IT number
- 08.08.
- Domain
- Human medicine
Packaging details
- Description (FR)
- EFLUELDA susp inj 2024/2025 ser pré 0.7 ml
- Description (DE)
- EFLUELDA Inj Susp 2024/2025 Fertspr 0.7 ml
- Market launch
- 16/08/2024
- Narcotic (BTM)
- No